Skip to main content
OpenTrials

Clinical trial condition

AL Amyloidosis

Explore clinical trials studying AL Amyloidosis. Study availability and eligibility vary by location and protocol.

55 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

AL Amyloidosis trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

NCT04512235

Conditions
AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +13 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
View all 110 locations
View Trial Details
Active, not recruiting

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

NCT04270175

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloid, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Boston University Medical Center Boston, Massachusetts, United States
  • Weill Cornell Medicine - Multiple Myeloma Center New York, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Active, not recruiting

Ixazomib Maintenance Study in Patients With AL Amyloidosis

NCT03618537

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Completed

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

NCT05184088

Conditions
AL Amyloidosis, ATTR Amyloidosis, Amyloid Neuropathies, +23 more
Locations
  • St Luke's Hospital Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • University of Augsburg Augsburg, Germany
View all 14 locations
View Trial Details
Completed

A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

NCT04617925

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Centre hospitalier Universitaire de Limoges - Limoges, France
  • University Hospital Heidelberg Heidelberg, Germany
  • General Hospital of Athens "Alexandra" Athens, Greece
  • Fondazione I.R.C.C.S Policlinico "San Matteo" Pavia, Italy
View Trial Details

Related conditions